
Alkosign (ALKOSIGN) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
124.4M
Gross Profit
-14.8M
-11.91%
Operating Income
4.3M
3.44%
Net Income
-4.8M
-3.88%
Balance Sheet Metrics
Total Assets
510.5M
Total Liabilities
180.7M
Shareholders Equity
329.9M
Debt to Equity
0.55
Cash Flow Metrics
Operating Cash Flow
55.6M
Free Cash Flow
24.0M
Revenue & Profitability Trend
Alkosign Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 515.3M | 356.9M | 213.8M | 101.6M | 132.4M |
Cost of Goods Sold | 385.5M | 230.3M | 137.3M | 56.9M | 71.7M |
Gross Profit | 129.8M | 126.6M | 76.5M | 44.7M | 60.8M |
Gross Margin % | 25.2% | 35.5% | 35.8% | 44.0% | 45.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 18.1M | 7.2M | 3.5M | 12.8M |
Other Operating Expenses | 29.8M | 32.3M | 13.4M | 8.7M | 4.0M |
Total Operating Expenses | 29.8M | 50.4M | 20.5M | 12.2M | 16.8M |
Operating Income | 53.9M | 20.5M | 8.8M | -7.8M | 11.9M |
Operating Margin % | 10.5% | 5.7% | 4.1% | -7.6% | 9.0% |
Non-Operating Items | |||||
Interest Income | - | 22.0K | 185.0K | 105.0K | 0 |
Interest Expense | 10.9M | 16.7M | 15.1M | 7.9M | 3.1M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 46.2M | 6.7M | -3.8M | -15.7M | 9.2M |
Income Tax | 8.5M | -1.2M | 767.0K | -1.9M | 2.5M |
Effective Tax Rate % | 18.4% | -17.8% | 0.0% | 0.0% | 27.6% |
Net Income | 37.7M | 7.8M | -4.6M | -13.8M | 6.6M |
Net Margin % | 7.3% | 2.2% | -2.1% | -13.6% | 5.0% |
Key Metrics | |||||
EBITDA | 81.3M | 47.9M | 30.8M | 8.9M | 14.2M |
EPS (Basic) | - | ₹1.22 | ₹-0.84 | ₹-4.35 | ₹1.22 |
EPS (Diluted) | - | ₹1.22 | ₹-0.84 | ₹-4.35 | ₹1.22 |
Basic Shares Outstanding | - | 6423770 | 5426190 | 3174000 | 5445000 |
Diluted Shares Outstanding | - | 6423770 | 5426190 | 3174000 | 5445000 |
Income Statement Trend
Alkosign Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 32.9M | 65.6M | 8.8M | 54.6M | 1.1M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 119.4M | 56.3M | 27.6M | 23.3M | 49.9M |
Inventory | 171.3M | 162.5M | 94.6M | 31.5M | 22.6M |
Other Current Assets | - | -1.0K | 2.0K | 1.0K | -1.0K |
Total Current Assets | 333.7M | 315.5M | 150.1M | 131.4M | 75.7M |
Non-Current Assets | |||||
Property, Plant & Equipment | 157.7M | 156.0M | 155.7M | 152.1M | 0 |
Goodwill | 11.8M | 12.2M | 12.5M | 13.5M | 14.5M |
Intangible Assets | 1.4M | 1.8M | 2.1M | 3.1M | 4.1M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 7.0M | -1.0K | 5.4M | 1.6M | 1.0K |
Total Non-Current Assets | 176.8M | 182.8M | 191.1M | 164.0M | 159.4M |
Total Assets | 510.5M | 498.3M | 341.2M | 295.4M | 235.1M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 40.1M | 57.2M | 11.6M | 4.9M | 19.4M |
Short-term Debt | 76.1M | 75.3M | 17.9M | 97.1M | 110.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 15.0M | -1.0K | 1.0K | 4.0M | 639.0K |
Total Current Liabilities | 131.3M | 143.0M | 33.5M | 106.0M | 133.8M |
Non-Current Liabilities | |||||
Long-term Debt | 49.4M | 63.1M | 186.1M | 63.2M | 94.4M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 97.0K |
Other Non-Current Liabilities | 1.0K | 1.0K | 1.0K | 1.0K | 1.0K |
Total Non-Current Liabilities | 49.4M | 63.1M | 186.1M | 63.2M | 94.5M |
Total Liabilities | 180.7M | 206.1M | 219.6M | 169.2M | 228.3M |
Equity | |||||
Common Stock | 72.0M | 72.0M | 54.4M | 54.4M | 100.0K |
Retained Earnings | - | -7.6M | -15.4M | -10.9M | 6.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 329.9M | 292.2M | 121.6M | 126.1M | 6.7M |
Key Metrics | |||||
Total Debt | 125.5M | 138.4M | 204.0M | 160.3M | 204.7M |
Working Capital | 202.4M | 172.5M | 116.6M | 25.4M | -58.1M |
Balance Sheet Composition
Alkosign Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 46.2M | 6.7M | -3.8M | -15.7M | 9.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -46.5M | -102.1M | -64.5M | -1.4M | -71.3M |
Operating Cash Flow | 10.6M | -78.8M | -53.2M | -8.7M | -59.1M |
Investing Activities | |||||
Capital Expenditures | -17.8M | -16.8M | -44.0M | -17.8M | -160.4M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | 0 | 0 | 0 | -1.0M |
Investment Sales | 1.0M | 0 | - | 116.0K | 0 |
Investing Cash Flow | -17.4M | -15.7M | -47.0M | -19.2M | -161.4M |
Financing Activities | |||||
Share Repurchases | - | - | -3.0K | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | 122.8M | - | 94.4M |
Debt Repayment | -13.8M | -65.6M | -79.2M | -44.4M | - |
Financing Cash Flow | -12.9M | 38.5M | -35.5M | 75.5M | 204.8M |
Free Cash Flow | -9.3M | -24.9M | -71.4M | -25.3M | -199.6M |
Net Change in Cash | -19.7M | -55.9M | -135.7M | 47.6M | -15.6M |
Cash Flow Trend
Alkosign Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
22.92
Price to Book
2.62
Price to Sales
2.51
Profitability Ratios
Profit Margin
7.32%
Operating Margin
3.44%
Return on Equity
12.12%
Return on Assets
6.68%
Financial Health
Current Ratio
2.54
Debt to Equity
38.05
Beta
-0.13
Per Share Data
EPS (TTM)
₹3.49
Book Value per Share
₹30.56
Revenue per Share
₹47.76
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
alkosign | 1.3B | 22.92 | 2.62 | 12.12% | 7.32% | 38.05 |
Doms Industries | 148.9B | 70.93 | 14.34 | 22.19% | 10.58% | 19.56 |
Flair Writing | 33.6B | 28.15 | 3.30 | 12.43% | 11.07% | 6.07 |
Control Print | 12.8B | 12.03 | 2.83 | 24.27% | 22.11% | 1.90 |
Kokuyo Camlin | 12.7B | 196.10 | 3.77 | 1.95% | 0.77% | 28.95 |
Trans India House | 1.2B | 41.34 | 2.20 | 5.07% | 2.37% | 160.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.